Nomenclature
CAS number: 298-57-7
1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine; 1-cinnamyl-4-diphenylmethylpiperazine;
N-benzhydryl-
N′-
trans-cinnamylpiperazine; 1-
trans-cinnamyl-4-diphenylmethylpiperazine; 1-cinnamyl-4-benzhydrylpiperazine; 1-diphenylmethyl-4-
trans-cinnamylpiperazine; cinnipirine; 516-MD; Aplactan (Eisai); Aplexal (Taiyo); Apotomin (Kowa); Artate (Nippon Chemiphar); Carecin (Zensei Yakuhin); Cerebolan (Tobishi); Cerepar (Mepha); Cinaperazine (Yakult); Cinazyn (Italchimici); Cinnacet (Schwarzhaupt); Cinnageron (Streuli); Corathiem (Ohta); Denapol (Nagase); Dimitron; Eglen (Tatsumi); Folcodal (Syncro); Giganten (Troponwerke); Glanil (Janssen); Hilactan (Kyoritsu); Ixertol (Rottendorf); Katoseran (Hishiyama); Labyrin; Midronal (Delalande); Mitronal (Searle); Olamin (Sigamed); Processine (Sanko); Sedatromin (Takata); Sepan (Janssen); Siptazin (Isei); Spaderizine (Kotobuki); Stugeron (Janssen); Stutgeron (Janssen); Stutgin; Toliman (Corvi).
C
26H
28N
2; mol wt 368.51.
C 84.74%, H 7.66%, N 7.60%.
Description and references
Calcium channel blocker with anti-allergic
and anti-vasoconstricting activity. Prepn: Janssen, US 2882271 (1959, Janssen). Pharmacology: Van Nueten,
Janssen, Arch. Int. Pharmacodyn. Ther. 204, 37 (1973). Metabolism: Soudijn, van Wijngaarden, Life Sci. 7, 231 (1968). Clinical
study in treatment of intermittent claudication: J. H. Barber et al., Pharmatherapeutica 2, 401 (1980). Assessment of calcium antagonist effects:
M. Spedding, Arch. Pharmacol. 318, 234 (1982). HPLC determn in blood and plasma:
M. Puttemans et al., J. Liq. Chromatogr. 7, 2237 (1984). Comparison of clinical pharmacokinetics
with other antihistamines: D. M. Paton, D. R. Webster, Clin. Pharmacokinet. 10, 477-497
(1985).
Antihistaminic. Vasodilator (peripheral, cerebral).
Antihistaminic; Piperazines; Calcium Channel Blocker; Piperazine Derivatives; Vasodilator (Cerebral); Vasodilator (Peripheral)